A pharmacokinetic and safety evaluation of a 28 day course of oral acyclovir in elderly patients with herpes zoster.
Moss
P J
PJ
Wood
M J
MJ
Crooks
R J
RJ
Gallagher
J
J
McKendrick
M W
MW
D000212:Acyclovir / Q000009:adverse effects* / Q000493:pharmacokinetics* / Q000627:therapeutic use; D000368:Aged; D000369:Aged, 80 and over; D000998:Antiviral Agents / Q000009:adverse effects* / Q000493:pharmacokinetics* / Q000627:therapeutic use; D005260:Female; D006562:Herpes Zoster / Q000188:drug therapy / Q000378:metabolism*; D006801:Humans; D008297:Male; D008875:Middle Aged
D000998:Antiviral Agents; D000212:Acyclovir